How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Build Back Better Act (H.R.5376); Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Build Back Better Act (H.R.5376); Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2022 · first_quarter · Q1
Restoring the America Invents Act (S.2891)
Build Back Better Act (H.R.5376); Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Restoring the America Invents Act (S.2891)
Build Back Better Act (H.R.5376); Affordable Insulin Now Act (H.R.6833/S.3700); Affordable Insulin for All Act (no bill number)
Elijah E. Cummings Lower Drug Costs Now Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
Elijah E. Cummings Lower Drug Costs Now Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
Elijah E. Cummings Lower Drug Costs Now Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Elijah E. Cummings Lower Drug Costs Now Act
Client: T1INTERNATIONAL USA · Firm: T1INTERNATIONAL USA
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
2021 · fourth_quarter · Q4
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
Build Back Better Act (H.R.5376); Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Insulin Affordability for All Act (no bill number)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2021 · third_quarter · Q3
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Elijah E. Cummings Lower Drug Costs Now Act (H.R.3); Affordable Insulin for All Act (H.R.4158); Emergency Access to Insulin Act (no bill number in current session)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2021 · second_quarter · RA
Issues related to insulin & diabetes related health care, access to medicines, and related patents.
Issues related to insulin & diabetes related health care, access to medicines, and related patents.
T1INTERNATIONAL USA via T1INTERNATIONAL USA
2021 · second_quarter · RA
Issues related to insulin & diabetes related health care, access to medicines, and related patents.
Issues related to insulin & diabetes related health care, access to medicines, and related patents.